Prophylaxis for Wound Infections and Endocarditis

  • Michelle Pipitone
  • Hugh M. GlosterJr.


There are three instances when prophylactic antibiotics are indicated: prophylaxis for prevention of a sugical site infection (SSI), prevention of endocarditis, and prevention of prosthesis infection. Postoperative SSI are a serious complication in cutaneous surgery, and although some limited guidelines exist, many physicians are unaware of the proper use of antibiotics.1, 2, 3 Furthermore, the emergence of resistant bacteria makes the prudent use of antibiotics crucial. A thorough understanding of the various factors related to SSI prophylaxis, the Centers for Disease Control and Prevention (CDC) guidelines pertaining to SSI prophylaxis, and proper antibiotic usage is vital to the practice of cutaneous surgery and will be discussed in this chapter. Treatment of definitive SSI is discussed in Chapter 5.


Atopic Dermatitis Surgical Site Infection Infective Endocarditis Antibiotic Prophylaxis Prophylactic Antibiotic 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Scheinfeld N, Struach S, Ross B. Antibiotic prophylaxis guideline awareness and antibiotic prophylaxis use among New York State dermatologic surgeons. Dermatol Surg 2002;28:841–844.CrossRefPubMedGoogle Scholar
  2. 2.
    George PM. Dermatoligsts and antibiotic prphylaxis: a survey. J Am Acad Dermatol 1995;33:418–421.CrossRefPubMedGoogle Scholar
  3. 3.
    Maragh SL, et al. Antibiotic prophylaxis in dermatologic surgery: updated guidelines. Dermatol Surg 2005;31:83–93.PubMedGoogle Scholar
  4. 4.
    Rabb DC, Lesher JL Jr. Antibiotic prohylaxis in cutaneous surgery. Dermatol Surg 1995;33:418–421.Google Scholar
  5. 5.
    Messingham MJ, Arpey CJ. Update on the use of antibiotics in cutaneous surgery. Dermatol Surg 2005;31:1068–1078.PubMedCrossRefGoogle Scholar
  6. 6.
    Hass AF, Grekin RC. Antibiotic prophylaxis in dermatologic surgery. J Am Acad Dermatol 1995;32:155–176.CrossRefGoogle Scholar
  7. 7.
    Billingsley E. The role of antibiotics in cutaneous surgery. Available at: Accessed October 2006.Google Scholar
  8. 8.
    Centers for Disease Control and Prevention. Guideline for prevention of surgical site infection, 1999. Available at: Accessed October 2006.Google Scholar
  9. 9.
    National Nosocomial Infection Survey (NNIS). Report, October 2004. Available at: Accessed October 2006.Google Scholar
  10. 10.
    Salache SJ. Acute surgical complications: cause, prevention, and treatment. J Am Acad Dermatol 1986;15:1163–1185.CrossRefGoogle Scholar
  11. 11.
    Garner JS. CDC guideline for prevention of surgical wound infections, 1985. Supercedes guideline for prevention of surgical wound infections published in 1982. (Originally published in November 1985). Revised. Infect Control 1986;7(3):193–200.PubMedGoogle Scholar
  12. 12.
    Hirschmann JV. Antimicrobial prophylaxis in dermatology. Semin Cutan Med Surg 200;19:2–9.CrossRefGoogle Scholar
  13. 13.
    Altemeier WA, et al. American College of Surgeons manual on control of infection in surgical patients. Philadelphia: Lippincott; 1994:133–139.Google Scholar
  14. 14.
    Cruse PJ, Foord R. The epidemiology of wound infection. A 10-year prospective study of 62,939 wounds. Surg Clin North Am 1980;60:27–40.PubMedGoogle Scholar
  15. 15.
    Futoryan T, Grande D. Postoperative wound infection rates in dermatologic surgery. Dermatol Surg 1995;21:509–514.CrossRefPubMedGoogle Scholar
  16. 16.
    Edwards PS, Lipp A, Holmes A. Preoperative skin antiseptics for preventing surgical wound infections after clean surgery. Cochrane Database Syst Rev 2004:CD003949.Google Scholar
  17. 17.
    Kluytmans JA, et al. Nasal carriage of S. aureus as a major risk factor for wound infections after cardiac surgery. J Infect Dis 1995;171:216–219.PubMedGoogle Scholar
  18. 18.
    Griego RD, Zitelli JA. Intra-incisional prophylactic antibiotics for dermatologic surgery. Arch Dermatol 1998;134:688–692.CrossRefPubMedGoogle Scholar
  19. 19.
    Johnson JT, Wagner RL. Infection following uncontaminated head and neck surgery. Arch Otolaryngol Head Neck Surg 1987;113:368–369.PubMedGoogle Scholar
  20. 20.
    Weber RS, Callender DL. Antibiotic prophylaxis in clean contaminated head and neck oncologic surgery. Ann Otol Rhinol Laryngol 1992;101:16–20.Google Scholar
  21. 21.
    Alster TS. Against antibiotic prophylaxis for cutaneous laser resurfacing. Dermatol Surg 2000;26:697–698.CrossRefPubMedGoogle Scholar
  22. 22.
    Friedman PM, Geronemus RG. Antibiotic prophylaxis in laser resurfacing patients. Dermatol Surg 2000;26:695–697.CrossRefPubMedGoogle Scholar
  23. 23.
    Gaspar Z, Vinciullo C, Elliott T. Antibiotic prophylaxis for full-face laser resurfacing: is it necessary? Arch Dermatol 2001;137:313–315.PubMedGoogle Scholar
  24. 24.
    Manuskiatti W, Fitzpatrick RE, Goldman MP, Krejci-Papa N. Prophylactic antibiotics in patients undergoing laser resurfacing of the skin. J Am Acad Dermatol 1999;40:77–84.CrossRefPubMedGoogle Scholar
  25. 25.
    Walia S, Alster TS. Cutaneous CO2 laser resurfacing infection rate with and without prophylactic antibiotics. Dermatol Surg 1999;25:857–861.CrossRefPubMedGoogle Scholar
  26. 26.
    Sriprachya-Anunt S, Fitzpatrick RE, Goldman MP, Smith SR. Infections complicating pulsed corbon dioxide laser resurfacing for photoaged facial skin. Dermatol Surg 1997;23:527–535.CrossRefPubMedGoogle Scholar
  27. 27.
    Ugburo AO, Atoyebi OA, Oyeneyin JO, Sowemimo GO. An evaluation of the role of systemic antibiotic prophylaxis in the control of burn wound infection at the Lagos University Teaching Hospital. Burns 2004;30:43–48.CrossRefPubMedGoogle Scholar
  28. 28.
    Hoffmann S. Siver sulfadiazine: an antibacterial agent for topical use in burns. A review of the literature. Scand J Plast Reconstr Surg 1984;18:119–126.CrossRefPubMedGoogle Scholar
  29. 29.
    Monafo WW, West MA. Current treatment recommendations for topical burn therapy. Drugs 1990;40:364–273.CrossRefPubMedGoogle Scholar
  30. 30.
    Shirani KZ, Vaughan GM, Mason AD Jr, Pruitt BA Jr. Update on current therapeutic approaches in burns. Shock 1996;5:4–16.CrossRefPubMedGoogle Scholar
  31. 31.
    Waldorf HA, Kauvar AN, Geronemus RG. Skin resurfacing of fine to deep rhytides using a char-free carbon dioxide laser in 47 patients. Dermatol Surg 1995;21:940–946.CrossRefPubMedGoogle Scholar
  32. 32.
    Weinstein C, Ramirez OM, Pozner JN. Postoperative care following CO2 laser resurfacing: avoiding pitfalls. Plast Reconstr Surg 1997;100:1855–1866.CrossRefPubMedGoogle Scholar
  33. 33.
    Beeson WH, Rachel JD. Valacyclovir prophylaxis for herpes simplex virus infection or infection recurrence following laser skin resurfacing. Dermatol Surg 2002;28:331–336.CrossRefPubMedGoogle Scholar
  34. 34.
    Gilbert S, McBurney E. Use of valacyclovir for herpes simplex virus 1 prophylaxis after facial resurfacing: a randomized clinical trial of dosing regimines. Dermatol Surg 2000;26:50–54.CrossRefPubMedGoogle Scholar
  35. 35.
    Gilbert S. Improving the outcome of facial resurfacingprevention of herpes simplex virus type 1 reactivation. J Antimicrob Chemother 2001:47(Suppl T1):29–34.CrossRefPubMedGoogle Scholar
  36. 36.
    Perkins SW, Sklarew EC. Prevention of facial herpetic infections after chemical peel and dermabrasion: new treatment strategies in the prophylaxis of patients undergoing procedures of the perioral area. Plast Reconstr Surg 1996;98:427–433.CrossRefPubMedGoogle Scholar
  37. 37.
    Bobrow BJ, Pollack CV Jr, Gamble S, Seligson RA. Incision and drainage of cutaneous abscesses is not associated with bacteremia in afebrile adults. Ann Emerg Med 1997;29:404–408.CrossRefPubMedGoogle Scholar
  38. 38.
    Smack DP, Harrington AC, Dunn C, et al. Infection and allergy incidence in ambulatory surgery patients using white petrolatum vs bacitracin ointment. A randomized controlled trial. JAMA 1996;276:972–977.CrossRefPubMedGoogle Scholar
  39. 39.
    Marks JG, Belsito DV, DeLeo VA, et al. North American Contact Dermatitis Group patch test results for the detection of delayed-type hypersensitivity to topical allergens. J Am Acad Dermatol 1998;38:911–918.CrossRefPubMedGoogle Scholar
  40. 40.
    Heinrich JJ, Brand DA, Cuono CB. The role of topical treatment as a determinant of infection in outpatient burns. J Burn Care Rehabil 1998;9:253–257.CrossRefGoogle Scholar
  41. 41.
    Campbell RM, Perlis CS, Fisher E, Gloster HM Jr. Gentamicin ointment versus petrolatum for management of auricular wounds. Dermatol Surg 2005;31:664–669.PubMedCrossRefGoogle Scholar
  42. 42.
    Huether MJ, Griego RD, Brodland DG, Zitelli JA. Clindamycin for intraincisional antibiotic prophylaxis in dermatologic surgery. Arch Dermatol 2002;138:1145–1148.CrossRefPubMedGoogle Scholar
  43. 43.
    Culver DH, Horan TC, Gaynes RP. Surgical wound infection rates by wound class, operative procedure, and patient risk index. National Nosocomial Infections Surveillance System. Am J Med 1991;16:91(3B):152S–157S.CrossRefGoogle Scholar
  44. 44.
    Perl TM, Golub JE. New approaches to reduce Staphlococcus aureus nosocomial infection rates: treating S. aureus nasal carriage. Ann Pharmacother 1998;32:S7–S16.PubMedGoogle Scholar
  45. 45.
    Perl TM, Cullen JJ, Wensel RP, et al. Intranasal mupriocin to prevent postoperative S. aureus infections. N Engl J Med 2002;346:1871–1877.CrossRefPubMedGoogle Scholar
  46. 46.
    Wenzel RP, Perl TM. The significance of nasal carriage of Staphylococcus aureus and the incidence of post-operative wound infection. J Hosp Infect 1995;31:13–24.CrossRefPubMedGoogle Scholar
  47. 47.
    Babcock MD, Grekin RC. Antibiotic use in dermatologic surgery. Dermatol Clin 2003:21:337–348.PubMedGoogle Scholar
  48. 48.
    Gilbert D, et al. Sanford guide to antimicrobial therapy. Antimicrobial Therapy, Inc; 2005:37.Google Scholar
  49. 49.
    Johns Hopkins Point of Care information technology. Surgical Site Injections. May 23, 2007. Available at: Scholar
  50. 50.
    Braun L, Craft D, Williams R, Tuamokumo F, Ottolini M. Increasing clindamycin resistance among methicillinresistant Staphylococcus aureus in 57 northeast United States military treatment facilities. Pediatr Infect Dis J 2005;24:622–626.CrossRefPubMedGoogle Scholar
  51. 51.
    Cao B, Wang H, Sun H, Zhu Y, Chen M. Risk factors for multlidrug-resistant Pseudomonas aeruginosa nosocomial infection. J Hosp Infect 2004;57:209–216.CrossRefGoogle Scholar
  52. 52.
    Halpern AC, Leyden JJ, Dzubow LM, McGinley KJ. The incidence of bacteremia in skin surgery of the head and neck. J Am Acad Dermatol 1988;19:112–116.CrossRefPubMedGoogle Scholar
  53. 53.
    Sabetta JB, Zitelli JA. The incidence of bacteremia during skin surgery. Arch Dermatol 1987;123:213–215.CrossRefPubMedGoogle Scholar
  54. 54.
    Maurice PD, Parker S, Azadian BS, Cream JJ. Minor skin surgery. Are prophylactic antibiotics ever needed for curettage? Acta Derm Venereol 1991;71:267–268.PubMedGoogle Scholar
  55. 55.
    Griffin MR, Wilson WR, Edwards WD, et al. Infective endocarditis: Olmsted County, Minnesota, 1950 through 1981. JAMA 1985;254:1199–1202.CrossRefPubMedGoogle Scholar
  56. 56.
    Spelman DW, Weinmann A, Spicer WJ. Endocarditis following skin procedures. J Infect 1993;26:185–189.CrossRefPubMedGoogle Scholar
  57. 57.
    Carmichael AJ, Flanagan PG, Holt PJ, Duerden BI. The occurrence of bacteraemia with skin surgery. Br J Dermatol 1996;134:120–122.CrossRefPubMedGoogle Scholar
  58. 58.
    Zack L, Remlinger K, Thompson K, Massa MC. The incidence of bacteremia after skin surgery. J Infect Dis 1989;159:148–150.PubMedGoogle Scholar
  59. 59.
    Dajani AS, Taubert KA, Wilson W, et al. Prevention of bacterial endocarditis. Recommendations by the American Heart Association. JAMA 1997;277:1794–1801.CrossRefPubMedGoogle Scholar
  60. 60.
    Durack DT, Kaplan EL, Bisno AL. Apparent failures of endocarditis prophylaxis: analysis of 52 cases submitted to a national registry. JAMA 1983;250:2318–2322.CrossRefPubMedGoogle Scholar
  61. 61.
    Cotrufo M, Carozza A, Romano G, De Feo M, Della Corte A. Infective endocarditis of native cardiac valves: 22 years’surgical experience. J Heart Valve Dis 2001;10:478–485.PubMedGoogle Scholar
  62. 62.
    Mandell GL, Bennett JE, Dolin R, eds. Non-injection drug abusers. In: Principles and practice of infectious diseases. 4th ed. New York: Churchill Livingstone; 1995:753.Google Scholar
  63. 63.
    Avierinos JF, Gersh BJ, Melton LJ 3rd, et al. Natural history of asymptomatic mitral valve prolapse in the community. Circulation 2002;106:1355–1361.CrossRefPubMedGoogle Scholar
  64. 64.
    Berney P, Fancioli P. Successful prophylaxis of experimental streptoccal endocarditis with single-dose amoxicillin administered after bacterial challenge. J Infect Disease 1990;161:281–285.Google Scholar
  65. 65.
    Affleck AG, Birnie AJ, Gee TM, Gee BC. Antibiotic prophylaxis in patients with valvular heart defects undergoing dermatological surgery remains a confusing issue despite apparently clear guidelines. Clin Exp Dermatol 2005;30:487–489.CrossRefPubMedGoogle Scholar
  66. 66.
    Wilson WR, Van Scoy RE, Washington JA. Incidence of bacteremia in adults without infection. J Clin Microbiol 1975;2:94–95.Google Scholar
  67. 67.
    Zack L, Remlinger K, Thompson K, et al. The incidence of bacteremia after skin surgery. J Infect Dis 1989;159:148–150.PubMedGoogle Scholar
  68. 68.
    Zahariadis G, Ross H. A crusty cause of prosthetic valve endocarditis. Can J Cardiol 1999;15:693–695.PubMedGoogle Scholar
  69. 69.
    Vanagt WY, Daenen WJ, Delhaas T. Propionibacterium acnes endocarditis on an annuloplasty ring in an adolescent boy. Heart 2004;90:e56.CrossRefPubMedGoogle Scholar
  70. 70.
    Harada M, Nishi Y, Tamura S, et al. Infective endocarditis with a huge mitral vegetation related to atopic dermatitis and high serum level of infection-related antiphospholipid antibody; a case report. J Cardiol 2003;42:135–140.PubMedGoogle Scholar
  71. 71.
    Conway DS, Taylor AD, Burrell CJ. Atopic eczema and staphylococcal endocarditis: time to recognize an association? Hosp Med 2000;61:356–357.PubMedGoogle Scholar
  72. 72.
    Onoda K, Mizutan H, Komada T, et al. Atopic dermatitis as a risk factor for acute native valve endocarditis. J Heart Valve Dis 2000;9:469–471.PubMedGoogle Scholar
  73. 73.
    Kobayashi H, Sugiuchi R, Tabata N, et al. Guess what! Acute infectious endocarditis with Janeway lesions in a patient with atopic dermatitis. Eur J Dermatol 1999;9:239–240.PubMedGoogle Scholar
  74. 74.
    Grabczynska SA, Cerio R. Infective endocarditis associated with atopic eczema. Br J Dermatol 1999;140:1193–1194.CrossRefPubMedGoogle Scholar
  75. 75.
    Pike MG, Warner JO. Atopic dermatitis complicated by acute bacterial endocarditis. Acta Paediatr Scand 1989;78:463–464.CrossRefPubMedGoogle Scholar
  76. 76.
    Americal Dental Association/American Academy of Orthopaedic Surgeons Expert Panel. Antibiotic prophylaxis for dental patients with total joint replacements. AAOS Bull; July 1997. Available at: Scholar
  77. 77.
    Hirschmann JV. Antimicrobial prophylaxis in dermatology. Semin Cutan Med Surg 2000;19:2–9.CrossRefPubMedGoogle Scholar
  78. 78.
    Segreti J, Levin S. The role of prophylactic antibiotics in the prevention of prosthetic device infections. Infect Dis Clin North Am 1989;3:357–370.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • Michelle Pipitone
    • 1
  • Hugh M. GlosterJr.
    • 1
  1. 1.Department of DermatologyUniversity of CincinnatiCincinnatiUSA

Personalised recommendations